Advancis Pharmaceutical is now MiddleBrook™ Pharmaceuticals, Inc.

In 2000, MiddleBrook Pharmaceuticals, Inc. made a novel discovery. Bacteria exposed to antibiotics in front-loaded, sequential bursts, or pulses, are killed more efficiently than those exposed to standard antibiotic treatment regimens.

Today, we are working to develop and commercialize pulsatile drug products, applying our patented finding to create a new outlook on anti-infective therapy.
+ Learn more.

Jul 22, 2008
MiddleBrook Pharmaceuticals to Conduct Investor Update Conference Call on July 24, 2008
+ more info

Jul 01, 2008
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM)
+ more info

May 13, 2008
MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results
+ more info